Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 92, Issue 25, 1995, Pages 11563-11567

  Collins, Peter L ^a   Hill, Myron G ^a   Camargo, Ena ^a   Grosfeld, Haim ^a   Chanock, Robert M ^a   Murphy, Brian R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Negative strand RNA virus; Paramyxovirus; Polymerase; Reverse genetics

Indexed keywords

HUMAN RESPIRATORY SYNCYTIAL VIRUS; PARAMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SYNCYTIAL VIRUS; MIRIDAE;

CAPSID PROTEIN; COMPLEMENTARY DNA; ELONGATION FACTOR; MESSENGER RNA; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN; VIRUS VACCINE;

ARTICLE; GENE EXPRESSION; HEP 2 CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS GENOME; VIRUS INFECTION; VIRUS NUCLEOCAPSID;

BASE SEQUENCE; CLONING, MOLECULAR; DNA, ANTISENSE; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, VIRAL; HN PROTEIN; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PLAQUE ASSAY; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC; TRANSFECTION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0029584042     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.92.25.11563     Document Type: Article

References (21)

1. Collins, P. L., McIntosh, K. & Chanock, R. M. (1995) in Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Raven, New York), 3rd Ed., in press.
2. Hall, C. B. (1994) Science 265, 1393-1394.
3. Murphy, B. R., Hall, S. L., Kulkarni, A. B., Crowe, J. E., Jr., Collins, P. L., Connors, M., Karron, R. A. & Chanock, R. M. (1994) Virus Res. 32, 13-36.
4. Lamb, R. A. & Kolakofsky, D. (1995) in Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Raven, New York), 3rd Ed., in press.
5. Pattniak, A. K., Ball, L. A., LeGrone, A. W. & Wertz, G. W. (1992) Cell 69, 1011-1020.
6. Calain, P. & Roux, L. (1993) J. Virol. 67, 4822-4830.
7. Conzelmann, K.-K. & Schnell, M. (1994) J. Virol. 68, 713-719.
8. Yu, Q., Hardy, R. W. & Wertz, G. W. (1995) J. Virol. 69, 2412-2419.
9. Grosfeld, H., Hill, M. G. & Collins, P. L. (1995) J. Virol. 69, 5677-5686.
10. Collins, P. L., Hill, M. G., Cristina, J. & Grosfeld, H. (1995) Proc. Natl. Acad. Sci. USA, in press.
11. Schnell, M. J., Mebatsion, T. & Conzelmann, K.-K. (1994) EMBO J. 13, 4195-4203.
12. Lawson, N. D., Stillman, E. A., Whitt, M. A. & Rose, J. K. (1995) Proc. Natl. Acad. Sci. USA 92, 4477-4481.
13. Collins, P. L., Hill, M. G. & Johnson, P. R. (1990) J. Gen. Virol. 71, 3015-3020.
14. Wyatt, L. S., Moss, B. & Rozenblatt, S. (1995) Virology 210, 202-205.
15. Murphy, B. R., Sotnikov, A. V., Lawrence, L. A., Banks, S. M. & Prince, G. A. (1990) Vaccine 8, 497-502.
16. Johnson, P. R. & Collins, P. L. (1988) J. Gen. Virol. 69, 2901-2906.
17. Zoller, M. J. & Smith, M. (1984) DNA 3, 479-488.
18. Connors, M., Crowe, J. E., Jr., Firestone, C. Y., Murphy, B. R. & Collins, P. L. (1995) Virology 208, 478-484.
19. Sidhu, M. S., Chan, J., Kaelin, K., Spielhofer, P., Radecke, F., Schneider, H., Masurekar, M., Dowling, P. C., Billeter, M. A. & Udem, S. A. (1995) Virology 208, 800-807.
20. Crowe, J. E., Jr., Bui, P. T., Davis, A. R., Chanock, R. M. & Murphy, B. R. (1994) Vaccine 12, 783-790.
21. Randhawa, J. S., Chambers, P., Pringle, C. R. & Easton, A. J. (1995) Virology 207, 240-245.